Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evolent Health's enterprise value was $1.41B on Nov 11, 2026, against $1.43B a year earlier. Over the last 5 years it ranged from $1.08B to $4.15B, with a median of $2.59B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.41B | +0.6% |
| 2025 | Dec 31, 2025 | $1.40B | -21.6% |
| 2024 | Dec 31, 2024 | $1.79B | -55.0% |
| 2023 | Dec 29, 2023 | $3.98B | +40.4% |
| 2022 | Dec 30, 2022 | $2.83B | +20.0% |
| 2021 | Dec 31, 2021 | $2.36B | +132.9% |
| 2020 | Dec 31, 2020 | $1.01B | +86.6% |
| 2019 | Dec 31, 2019 | $543.55M | -57.1% |
| 2018 | Dec 31, 2018 | $1.27B | +174.4% |
| 2017 | Dec 29, 2017 | $461.53M | -37.2% |
| 2016 | Dec 30, 2016 | $734.64M | +120.7% |
| 2015 | Dec 31, 2015 | $332.92M | – |
See a number that looks wrong?